Key result
Screening a human heart cDNA library with acute rheumatic fever serum identified 12 autoreactive antigens, with patients showing significantly higher antibody levels than controls.
The identification of 12 novel cardiac autoantigens in ARF provides promising candidates for the development of a diagnostic serological assay.
These autoantigens may aid future ARF serodiagnostics; leaves open validation and clinical utility in prospective human studies.
Acute rheumatic fever (ARF) is an autoimmune sequela of group A streptococcal infection mostly affecting school-aged children. Recurrent episodes of ARF can result in the development of rheumatic heart disease (RHD). One in 40 indigenous Australians in the Northern Territory is affected by RHD. This disease mostly impacts young people; 45% of those who require heart valve surgery in Australia due to RHD are younger than 25 years old. ARF is characterized by autoimmune attack of the heart; therefore, the presence of the autoantibodies involved could potentially be used to diagnose ARF. To this end, a human heart cDNA library was screened with serum from a patient with ARF, and 12 autoreactive human heart antigens were identified. They include five different IgG heavy chains and a range of tissue-specific cell-signaling proteins, species of which have been implicated in other autoimmune diseases. Preliminary ELISA results show that ARF patients have significantly higher levels of antibodies recognizing the cardiac autoantigens than controls. These antigens are promising candidates for the development of a serological assay for the diagnosis of ARF. The nature of the proteins identified has exciting implications for future research into the pathogenesis of ARF.
No takes yet. Share an insight, caveat, or question.
Towers et al. (2009) studied Acute rheumatic fever. Acute rheumatic fever sera vs. Controls was evaluated on Levels of antibodies recognizing cardiac autoantigens. Screening a human heart cDNA library with acute rheumatic fever serum identified 12 autoreactive antigens, with patients showing significantly higher antibody levels than controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: